CovalX

CovalX AG is a Zürich, Switzerland-based biotechnology research company that develops analytical solutions for the characterization of biotherapeutics for the life science industry.

Origins
A spin-off of the Swiss Federal Institute of Technology (ETHZ), CovalX was founded by Ryan Wenzel, Alexis Nazabal, and Urs Matter in 2005 as CovalX GmbH and was converted in January 2007 to AG status to allow additional investors into the company.

In 2011, CovalX founded a US subsidiary called CovalX Instruments Incorporated, located in the Boston area. They began manufacturing and testing their equipment, as well as sales and support for their hardware products.

After establishing its first laboratory in Zürich, CovalX founded laboratories in Boston (2011) and Bordeaux (2017).

One focus of CovalX was measuring intact protein complexes by MALDI mass spectrometry. They distribute chemical kits, high mass detection hardware, and analysis software.

In 2009, CovalX began focusing on analytical service measurements through its growing CRO laboratories in Switzerland and France.

Awards
In April 2006, CovalX received the CTI Start-up Label from the Swiss Confederation's Commission for Technology and Innovation.